» Articles » PMID: 26451340

Mutations in TJP2, Encoding Zona Occludens 2, and Liver Disease

Overview
Journal Tissue Barriers
Date 2015 Oct 10
PMID 26451340
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive familial intrahepatic cholestasis is a clinical description of a phenotype, which we now realize has several different genetic aetiologies. The identification of the underlying genetic defects has helped to elucidate important aspects of liver physiology. The latest addition to this family of diseases is tight junction protein 2 (TJP2) deficiency. This protein is also known as zona occludens 2 (ZO-2). The patients, so far presented, all have homozygous, protein-truncating mutations. A complete absence of this protein was demonstrated. These children presented with severe liver disease, some manifesting extrahepatic features. By contrast, embryonic-lethality was seen in ZO-2 knockout mice. This discovery highlights important differences, not just between species, but also between different epithelia in humans. This commentary discusses the recently presented findings, and some of the issues that arise.

Citing Articles

A Novel Compound Heterozygous Mutation in Progressive Familial Intrahepatic Cholestasis (PFIC) 4: A Rare Case Report With Literature Review.

Pandey D, Chandnani S, Gandhi H, Vishal M, Rathi P Cureus. 2024; 16(11):e73927.

PMID: 39697951 PMC: 11654999. DOI: 10.7759/cureus.73927.


Progressive familial intrahepatic cholestasis type 4: a case report.

Abokandil M, Waheeb S, Zaghloul W, Abdelgawad M, Abdelhady M, Mansy M J Med Case Rep. 2024; 18(1):434.

PMID: 39243110 PMC: 11380191. DOI: 10.1186/s13256-024-04662-5.


Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center.

Alsohaibani F, Peedikayil M, Alfadley A, Aboueissa M, Abaalkhail F, Alqahtani S Int J Hepatol. 2023; 2023:1960152.

PMID: 37520499 PMC: 10374379. DOI: 10.1155/2023/1960152.


Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency.

Felzen A, van Wessel D, Gonzales E, Thompson R, Jankowska I, Shneider B JHEP Rep. 2023; 5(2):100626.

PMID: 36687469 PMC: 9852554. DOI: 10.1016/j.jhepr.2022.100626.


Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency.

Li C, Ogawa H, Ng S, Chen X, Kishimoto E, Sakabe K JHEP Rep. 2022; 4(4):100446.

PMID: 35284810 PMC: 8904612. DOI: 10.1016/j.jhepr.2022.100446.


References
1.
Neu-Yilik G, Amthor B, Gehring N, Bahri S, Paidassi H, Hentze M . Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon. RNA. 2011; 17(5):843-54. PMC: 3078734. DOI: 10.1261/rna.2401811. View

2.
Lykavieris P, van Mil S, Cresteil D, Fabre M, Hadchouel M, Klomp L . Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol. 2003; 39(3):447-52. DOI: 10.1016/s0168-8278(03)00286-1. View

3.
de Vree J, Jacquemin E, Sturm E, Cresteil D, Bosma P, Aten J . Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A. 1998; 95(1):282-7. PMC: 18201. DOI: 10.1073/pnas.95.1.282. View

4.
Sambrotta M, Strautnieks S, Papouli E, Rushton P, Clark B, Parry D . Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet. 2014; 46(4):326-8. PMC: 4061468. DOI: 10.1038/ng.2918. View

5.
Kuipers F, Bloks V, Groen A . Beyond intestinal soap--bile acids in metabolic control. Nat Rev Endocrinol. 2014; 10(8):488-98. DOI: 10.1038/nrendo.2014.60. View